JP Morgan analyst Anupam Rama downgrades Cyteir Therapeutics (NASDAQ:CYT) from Overweight to Neutral.
Top 3 Real Estate Stocks That May Crash In Q3
The most overbought stocks in the real estate sector presents an opportunity to go short on these overvalued companies.